Forfang K - Search Results

1

Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes.

Aukrust P, Berge RK, Ueland T, Aaser E, Damås JK, Wikeby L, Brunsvig A, Müller F, Forfang K, Frøland SS, Gullestad L. Aukrust P, et al. Among authors: forfang k. J Am Coll Cardiol. 2001 Feb;37(2):485-91. doi: 10.1016/s0735-1097(00)01110-4. J Am Coll Cardiol. 2001. PMID: 11216967 Free article.

2

Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes.

Aukrust P, Müller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Frøland SS, Gullestad L. Aukrust P, et al. Among authors: forfang k. Circulation. 1999 Aug 10;100(6):614-20. doi: 10.1161/01.cir.100.6.614. Circulation. 1999. PMID: 10441098

3

[Drug therapy of angina pectoris. Are the possibilities exploited well enough?].

Forfang K, Gullestad L. Forfang K, et al. Tidsskr Nor Laegeforen. 1995 Aug 10;115(18):2264-7. Tidsskr Nor Laegeforen. 1995. PMID: 7652725 Norwegian.

4

Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.

Aaser E, Gullestad L, Tølløfsrud S, Lundberg J, Hall C, Djøseland O, Kjekshus J, Forfang K. Aaser E, et al. Among authors: forfang k. Scand J Clin Lab Invest. 1997 Jul;57(4):361-7. doi: 10.3109/00365519709099409. Scand J Clin Lab Invest. 1997. PMID: 9249883 Clinical Trial.

5

[Current use of beta-blockers in coronary artery disease].

Gullestad L, Bjørnerheim R, Offstad J, Endresen K, Forfang K, Kjekshus J, Hansteen V. Gullestad L, et al. Among authors: forfang k. Tidsskr Nor Laegeforen. 1999 Jan 10;119(1):24-8. Tidsskr Nor Laegeforen. 1999. PMID: 10025200 Norwegian.

6

Differential effect of selective beta 1 and nonselective beta-adrenoceptor blockade on epinephrine and atropine response in normal humans.

Gullestad L, Forfang K, Simonsen S. Gullestad L, et al. Among authors: forfang k. J Cardiovasc Pharmacol. 1992 Dec;20(6):976-81. doi: 10.1097/00005344-199212000-00019. J Cardiovasc Pharmacol. 1992. PMID: 1282602 Clinical Trial.

7

A descriptive study of early nonspecific chest pain after PTCA: important area for the acute health care personnel.

Ronnevig M, Bjorsvik E, Gullestad L, Forfang K. Ronnevig M, et al. Among authors: forfang k. Heart Lung. 2003 Jul-Aug;32(4):241-9. doi: 10.1016/s0147-9563(03)00024-4. Heart Lung. 2003. PMID: 12891164

8

Post-transplant hyperlipidaemia: low-dose lovastatin lowers atherogenic lipids without plasma accumulation of lovastatin.

Gullestad L, Nordal KP, Forfang K, Ihlen H, Høstmark A, Berg KJ, Cheng H, Schwartz MS, Geiran O, Simonsen S. Gullestad L, et al. Among authors: forfang k. J Intern Med. 1997 Dec;242(6):483-90. doi: 10.1111/j.1365-2796.1997.tb00021.x. J Intern Med. 1997. PMID: 9437409 Free article.

9

Continued symptomatic improvement three to five years after transmyocardial revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial revascularization.

Aaberge L, Rootwelt K, Blomhoff S, Saatvedt K, Abdelnoor M, Forfang K. Aaberge L, et al. Among authors: forfang k. J Am Coll Cardiol. 2002 May 15;39(10):1588-93. doi: 10.1016/s0735-1097(02)01828-4. J Am Coll Cardiol. 2002. PMID: 12020484 Free article. Clinical Trial.

10

[Treatment of terminal heart failure].

Simonsen S, Forfang K, Gullestad L, Geiran O. Simonsen S, et al. Among authors: forfang k. Tidsskr Nor Laegeforen. 1995 Feb 10;115(4):467-70. Tidsskr Nor Laegeforen. 1995. PMID: 7871502 Norwegian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters